A Study at the Center of the Abortion Pill Battle Was Just Retracted
Feb 8, 2024
auto_awesome
Discussion on the retraction of a controversial study linking the abortion pill to emergency room visits, concerns about methodology and conflicts of interest. Exploration of the safety of the abortion pill, challenges faced by patients, misclassification of emergency room visits, and legal battles surrounding its approval.
Scientific publisher Sage Journals retracted a study on Mipha-Pristone, which claimed that the medication significantly increased women's risk of going to the emergency room post-abortion due to inaccuracies in data presentation and problems with the study's methodology.
Critics argued that the study wrongly equated emergency room visits with serious complications in medication abortion, pointing out that patients often seek ER visits for side effects or confirmation of abortion success, and existing research indicates that Mipha-Pristone has low complication rates.
Deep dives
Study on Mipha-Pristone's risks post-abortion retracted
Scientific publisher Sage Journals retracted three papers on abortion, including a 2021 study on Mipha-Pristone. The study claimed that the medication significantly increased women's risk of going to the emergency room post-abortion. Sage issued a retraction notice, stating that an independent reviewer found inaccuracies in the data presentation and problems with the study's methodology. The retracted papers were a basis for a U.S. ruling invalidating the FDA's approval of the drug.
Misleading ER visit data and concerns over complications
A study on medication abortion's emergency room (ER) visits was found problematic by critics. They argued that ER visits were wrongly equated with serious complications, which the study did not assess. Critics pointed out that medication abortion often causes bleeding, and some patients seek ER visits for side effects or confirmation of abortion success. Existing research indicates that Mipha-Pristone has low complication rates, although the FDA recorded 32 deaths without direct causation attribution.
A scientific publisher found serious flaws in a paper that links the medication mifepristone to more emergency room visits.Thanks for listening to WIRED. Talk to you next time for more stories from WIRED.com and read this story here.